TAOX earnings: next report 2026-08-07, real EPS beat/miss history, P/E -0.27. Updated 2026-07-23.
TAO Synergies (TAOX) Research Hub
TAO Synergies (TAOX) trades on NASDAQ, US in the Technology (Biotechnology) sector. As of 2026-09-11, shares last closed at 3.9 USD (-3.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.27, market cap 0.01B. This hub links to the full technical, earnings and options research available for TAOX.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Technology (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.9 USD (-3.23%) |
| 52-week range | 3.07 USD – 4.29 USD |
| Trend regime | Range |
| 14-day RSI | 64 (Bullish) |
| Trailing P/E | -0.27 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-07 |
Available research for TAOX
Covered Call on TAOX: how it works, illustrative setup around the real 3.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on TAOX: how it works, illustrative setup around the real 3.9 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on TAOX: how it works, illustrative setup around the real 3.9 USD price, max profit/loss, breakeven and when to use it. Educational.
TAOX technical analysis: range, last 3.9 USD, RSI 64, 52w range 3.07 USD–4.29 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is TAOX in?
TAO Synergies (TAOX) is classified under Technology (Biotechnology), listed on NASDAQ, US.
Is TAOX in an uptrend or downtrend?
As of 2026-09-11, TAOX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is TAOX's trailing P/E ratio?
TAOX's trailing P/E is -0.27, with a market cap of 0.01B. See the earnings research page for full valuation detail.
When does TAOX next report earnings?
TAOX is next scheduled to report earnings on 2026-08-07, with a consensus EPS estimate of -12.75 USD.